Recent insider trading activity from Huston Thad Allen, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | Artiva Biotherapeutics, Inc. | $ARTV | Huston Thad Allen | Chief Financial Officer | A | Common Stock | 220000 | $0.00 | 220,000.0000 | 24,544,904 | 9999.99% | 0.90% |